Dialkyl or alkyl aryl esters of 1,2-benzenedicarboxylic acid, commonly called phthalates, are ubiquitous industrial chemicals with a wide range of chemical and toxicologic characteristics. Phthalates are used primarily as plasticizers in flexible polyvinyl chloride (PVC) products such as blood bags and children's toys. Nonpolymeric uses of phthalates as fixatives, detergents, lubricating oils, and solvents lead to their inclusion in numerous and diverse products such as cosmetics and wood finishes. The widespread use of phthalates results in multiple human exposure routes (oral, dermal, inhalation, and intravenous). Phthalates are lipophilic compounds that appear not to bioaccumulate (1). Phthalates are rapidly metabolized to their respective monoesters and further oxidative products, which are glucuronidated and excreted through the urine and feces (1-4).Animal toxicology of several phthalates has been studied. Di-(2-ethylhexyl) phthalate (DEHP) is a rodent liver carcinogen through a mechanism thought to involve peroxisome proliferation (5); however, carcinogenicity by this mechanism is unlikely to be relevant to humans (6,7). Several phthalates, DEHP, dibutyl phthalate (DBP), and benzyl butyl phthalate (BzBP), are teratogenic in animals (8-10). DBP is also toxic to the testes, possibly through its metabolite, monobutyl phthalate (MBP) (11,12); other phthalate metabolites, monobenzyl phthalate (MBzP) and mono-2-ethylhexyl phthalate (MEHP), are Sertoli cell toxicants and teratogens in animals (13,14). Furthermore, administration of DBP and DEHP to pregnant rats interferes with normal fetal development in male offspring (15). Regarding reproductive and developmental effects, phthalates vary in potency, with DEHP being the most potent and DBP and BzBP roughly an order of magnitude less potent (8)(9)(10)(11)(12)(13)(14)(15).Based on the varied toxicities of phthalates, internal dose measurements of specific phthalates and their monoester metabolites (16) are important for exposure assessment, and ultimately for accurate human risk assessment. Previous methods for assessing human exposure to phthalates have been subject to laboratory and sample-collection contamination problems from these environmentally ubiquitous compounds (17)(18)(19)(20). For this reason, previous measurements of internal phthalate dose have focused on highly exposed people (21,22). As the primary urinary metabolite, phthalate monoesters are useful biomarkers of specific phthalate exposure.We report the urinary phthalate monoester levels for a human reference population using a new, highly selective technique (23). This analytical approach allows us to directly measure the individual phthalate metabolites responsible for the reproductive and developmental toxicity of phthalates in animals while avoiding contamination from the ubiquitous parent compound. The metabolites measured are monoethyl phthalate (MEP), MBP, MBzP, mono-n-octyl phthalate, MEHP, and mono-3-methyl-5-dimethylhexyl phthalate (monoisononyl, MINP). Commercially used di-isononyl p...